Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Mohammad Rafieetary, OD, FAAO
Advertisement
Articles by Mohammad Rafieetary, OD, FAAO
Advertisement
Latest Updated Articles
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lweyPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Kodiak Sciences releases follow-up, 20-week data from APEX study
2
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
3
From then to next: Five decades of transformation in ophthalmology
4
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
5
.png "Optometry Times"){kind=logo}
